AAM Launches Further Broadside At Proposed Blocking Act

Proposed Act ‘Well-Intended But Misguided,’ AAM Claims

Delays
Weakening the 180-day exclusivity incentive will delay patient access, the AAM insists • Source: Shutterstock

More from Policy & Regulation

More from Generics Bulletin